US FDA declines to approve Ultragenyx's gene therapy for rare genetic disorder

  • The U.S. Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical's experimental gene therapy to treat a rare genetic disorder, the company said on Friday.